The Neurocognition working group aims to investigate how COVID-19 affects cognitive function in the brain and nervous system.

Some of the questions we will be asking:

  • Does COVID-19 infection affect cognitive function?
  • What are the underlying neurological/clinical substrates of cognitive impairment associated with COVID-19?
  • What specific components of the cognitive system (e.g., memory, attention, executive function, visuospatial processing, language) are most/least impaired? How do the patterns of affected components change over time/during recovery?
  • What factors (e.g., age, severity of infection) predict the severity and patterns of cognitive impairments associated with COVID-19?
  • What factors predict recovery/outcomes for patients with cognitive difficulties?
  • How do we separate apparent cognitive impairment from confounders such as fatigue and depression?



Back to: COVID-19 Clinical Neuroscience Study (COVID-CNS)